Boehringer Ingelheim Launches MindBodyHAART.com, a Comprehensive Online Resource for the HIV/AIDS Community

Web Site Offers Expert Videos, Downloadable Educational Information, Tips for Living a Healthier Life and Resources for Patient Assistance Programs

Ridgefield, CT., December 1, 2009 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. today announced the launch of the Mind, Body, HAART Web site (www.MindBodyHAART.com), a single-destination resource for people living with HIV, people affected by HIV and those caring for people with HIV. The site provides tools and helpful tips on how to maintain mental, physical and emotional well-being when dealing with the daily challenges of the disease.

“MindBodyHAART.com is a resource for the HIV community at large, which recognizes the need for a team approach to successful HIV management,” says Valerie Wojciechowicz, an HIV patient educator living with HIV for over 20 years. “BI has created an informational resource to inform and support the entire HIV community—from patients and their families, to caregivers and educators—and help anyone affected by the disease to identify ways for dealing with it more effectively.”

MindBodyHAART.com can help patients, families and caregivers:

• Understand issues that can affect HIV care and treatment success, which can include relationships with healthcare providers, getting needed emotional support, sticking with a treatment plan and having other medical conditions.
• Manage their health regimens by providing tips on keeping medical appointments, communicating with healthcare providers, participating in treatment decisions and adhering to prescribed HIV therapy.
• Find resources to apply for financial support for prescription medications and participate in clinical trials.

MindBodyHAART.com can help physicians & HIV/AIDS educators:

• Focus on key HIV management issues, which can include health issues that may influence patient care, the unique needs of women and the importance of identifying a therapy that fits a patient’s individual needs.
• Provide information and tools to help guide patients as they work with their healthcare teams to determine appropriate care.

The features of MindBodyHAART.com for patients, families, caregivers, physicians and HIV/AIDS educators include:

• Useful advice, facts and information about HIV
• Information on how to work with healthcare providers to find the right therapy
• Downloadable educational information and HIV management resources, such as patient assistance programs
• Videos with experts on topics including mental and emotional well-being, physical health and therapy options
• Tips to live a healthier life, including the unique health concerns of men and women, treatment adherence advice, treatment options, potential treatment side effects and other medical conditions for which patients may be at risk
• Downloadable educational information to share with patients, clients or the community

About MindBodyHAART.com

For nearly 125 years, Boehringer Ingelheim has focused on discovering innovative ways—through both science and disease education—to improve the quality of life for patients and their families. MindBodyHAART.com is a primary example of this dedication as the Web site was created to provide useful advice, facts and information for patients, caregivers, physicians and community educators. The goal of the site is to help enhance HIV/AIDS care and treatment by fostering an open dialogue. The site’s namesake encompasses the mental and emotional (MIND), physical (BODY) and treatment (HAART) challenges that come with living with HIV.

Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and approximately 41,300 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com

###